Aim:
Trends in Pharmaceutical Biotechnology is dedicated to advancing the frontiers of knowledge in the dynamic and rapidly evolving field of Pharmaceutical Biotechnology. Our journal is committed to capturing the pulse of innovation by featuring authoritative reviews, pioneering original research articles, and insightful letters contributed by leading experts in the discipline. Encompassing a diverse range of contemporary themes within the realm of Pharmaceutical Biotechnology, each issue aims to be a compass for navigating the latest developments in this dynamic field.
Scope:
The journal's purview is expansive, covering but not limited to the following pivotal scientific areas of pharmaceutical biotechnology:
- mRNA Vaccines: Building on the triumph of mRNA vaccines for COVID-19, our journal delves into the forefront of research exploring the broader applications of mRNA technology for infectious diseases and cancer.
- CRISPR-Cas9 in Drug Discovery: Unleashing the potential of CRISPR-Cas9 gene-editing, we investigate its revolutionary impact on target identification and validation in drug discovery, ushering in an era of precision medicine.
- Biopharmaceuticals and Monoclonal Antibodies: Ongoing research on biopharmaceuticals, particularly monoclonal antibodies, unfolds within our pages, shedding light on their potential in treating diverse ailments, from autoimmune disorders to cancers.
- Gene and Cell Therapies: Our journal explores cutting-edge developments in gene therapy, utilizing viral vectors for therapeutic gene delivery, and the burgeoning field of cell therapies, exemplified by the revolutionary CAR-T cell therapy for cancer.
- Personalized Medicine: Embracing the paradigm shift toward personalized medicine, we integrate genetic information to optimize drug selection and dosage, striving for enhanced efficacy and minimized side effects.
- Nanotechnology in Drug Delivery: Unveiling the potential of nanoparticles and nanocarriers, our journal examines their role in targeted drug delivery, with the overarching goal of improving bioavailability, reducing side effects, and optimizing therapeutic outcomes.
- Biosimilars: We continue to showcase advancements in biosimilar development, highlighting products that closely mirror FDA-approved reference products, and fostering a deeper understanding of their clinical implications.
- Drug Repurposing: Recognizing the cost-effective potential of drug repurposing, our journal explores novel therapeutic applications for existing drugs across various diseases.
- Immunotherapy: Cutting-edge research on immunotherapies, encompassing checkpoint inhibitors and cancer vaccines, unfolds within our pages, exploring their potential in treating various cancers by harnessing the body's immune system.
- Regenerative Medicine: Our commitment extends to the exploration of regenerative medicine, covering research on the repair, replacement, and regeneration of damaged tissues.
- Tissue Engineering: Our pages feature the latest developments in the development and application of engineered tissues, providing insights into the transformative potential of tissue engineering.
The overarching mission of Trends in Pharmaceutical Biotechnology is to provide an inclusive platform for disseminating groundbreaking research, with a strong emphasis on translating scientific discoveries into innovative products and therapies. By fostering collaboration between academia and industry, our journal actively promotes the application of biotechnology for the betterment of patients and society.